Gaois

Search direction

Search mode

Filter results

Collections

9 results in 4 documents

  1. #2129647

    “Cneasaitheoirí ag a bhfuil an cód CAT D03AX

    ‘Cicatrizants with ATC code D03AX

    Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features (Text with EEA relevance)

  2. #3061181

    An Cód CAT (an Cód Ceimiceach Teiripeach Anatamaíoch)

    ATC code (Anatomical Therapeutic Chemical Code)

    Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2023 to 28 February 2023 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)

  3. #2129617

    Níl an chatagóir táirgí “cneasaitheoirí ag a bhfuil an cód CAT D03AX” ina bhfuil an fhoirm chógaisíochta “larbhaí cuileoige” san áireamh sa liosta sin.

    The product category ‘cicatrizants with ATC code D03AX’ with pharmaceutical form ‘fly larvae’ is not included in that list.

    Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features (Text with EEA relevance)

  4. #641817

    Má dhéantar triail chliniciúil a stiúradh le substaint ghníomhach atá ar fáil san Aontas faoi thrádainmneacha éagsúla i roinnt táirgí íocshláinte údaraithe, féadfar sainiú a thabhairt sa phrótacal ar an gcóireáil i dtéarmaí na substainte gníomhaí nó an chóid le haghaidh Ceimiceáin Anatamaíoch Theiripigh (CAT leibhéal 3-5) amháin gan trádainm gach táirge a shonrú.

    If a clinical trial is conducted with an active substance available in the Union under different trade names in a number of authorised medicinal products, the protocol may define the treatment in terms of the active substance or Anatomical Therapeutic Chemical (ATC) code (level 3-5) only and not specify the trade name of each product.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  5. #641919

    Má dhéantar an táirge íocshláinte imscrúdaitheach a shainiú sa phrótacal i dtéarmaí substainte gníomhaí nó an chóid CAT (féach thuas, mír 18), féadfaidh an t-iarratasóir SmPC ionadaíoch amháin a chur in ionad an STMI i gcás gach substainte gníomhaí/gach substainte gníomhaí a bhaineann leis an ngrúpa CAT sin.

    If the investigational medicinal product is defined in the protocol in terms of active substance or ATC code (see above, paragraph 18), the applicant may replace the IMPD by one representative SmPC for each active substance/active substance pertaining to that ATC group.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  6. #2129605

    lena leasaítear Rialachán Tarmligthe (AE) 2016/161 a mhéid a bhaineann le fógraí ó údaráis náisiúnta chuig an gCoimisiún a mheas agus cneasaitheoirí ag a bhfuil an cód CAT D03AX agus an fhoirm chógaisíochta larbhaí cuileoige a áireamh i liosta na gcógas nach mbeidh na gnéithe sábháilteachta orthu

    amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features

    Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features (Text with EEA relevance)

  7. #2129618

    An 22 Lúnasa 2019, fuair an Coimisiún fógra ó údarás inniúil na Gearmáine inar sonraíodh gur mheas sé nach raibh baol ann go bhfalsófaí an táirge íocshláinte Biobag (cód CAT D03AX agus an fhoirm chógaisíochta “larbhaí cuileoige”) i gcomhréir leis na critéir a leagtar amach in Airteagal 54a(2), pointe (b), de Rialachán 2001/83/CE, agus gur cheart, dá bhrí sin, an táirge íocshláinte a dhíolmhú ón gceanglas gnéithe sábháilteachta a bheith air.

    On 22 August 2019, the Commission received a notification from the competent German authority stating that it deemed the prescription medicinal product BioBag (ATC code D03AX and pharmaceutical form ‘fly larvae’) not to be at risk of falsification in accordance with the criteria set out in Article 54a(2), point (b), of Directive 2001/83/EC, and that the medicinal product should therefore be exempted from the requirement to bear safety features.

    Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features (Text with EEA relevance)

  8. #2129622

    Dá bhrí sin, is iomchuí an chatagóir táirgí “cneasaitheoirí ag a bhfuil an cód CAT D03AX” ina bhfuil an fhoirm chógaisíochta “larbhaí cuileoige” a áireamh i liosta na dtáirgí íocshláinte nó na gcatagóirí táirgí atá faoi réir oideasú nach mbeidh na gnéithe sábháilteachta orthu a leagtar amach in Iarscríbhinn I a ghabhann le Rialachán Tarmligthe (AE) 2016/161.

    It is, therefore, appropriate to include the product category ‘cicatrizants with ATC code D03AX’ with pharmaceutical form ‘fly larvae’ in the list of medicinal products or product categories subject to prescription that shall not bear the safety features, set out in Annex I to Delegated Regulation (EU) 2016/161.

    Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features (Text with EEA relevance)

  9. #3099495

    Rialachán Tarmligthe (AE) 2021/1686 ón gCoimisiún an 7 Iúil 2021 lena leasaítear Rialachán Tarmligthe (AE) 2016/161 a mhéid a bhaineann le fógraí ó údaráis náisiúnta chuig an gCoimisiún a mheas agus cneasaitheoirí ag a bhfuil an cód CAT D03AX agus an fhoirm chógaisíochta larbhaí cuileoige a áireamh i liosta na gcógas nach mbeidh na gnéithe sábháilteachta orthu, tá sé le hionchorprú i gComhaontú LEE.

    Commission Delegated Regulation (EU) 2021/1686 of 7 July 2021 amending Delegated Regulation (EU) 2016/161 as regards the evaluation of notifications by national competent authorities to the Commission and the inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features is to be incorporated into the EEA Agreement.

    Decision of the EEA Joint Committee No 334/2021 of 10 December 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/648]